Search filters

List of works by Angela Dispenzieri

'Hypersynchronisation' by tissue velocity imaging in patients with cardiac amyloidosis

scientific article published on 12 May 2008

18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves

scientific article published on 18 August 2015

6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance

scientific article

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

scientific article published on 01 January 2007

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published on June 2010

A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment

scientific article published on December 2012

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

scientific article

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

scientific article published on June 2013

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

scientific article

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

scientific article

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

scientific article published on 4 September 2017

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.

scientific article published on 26 May 2017

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published in January 2005

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

scientific article published on 31 December 2012

A phase II trial of imatinib in patients with refractory/relapsed myeloma

scientific article published on January 2006

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

scientific article published on 20 August 2012

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

scientific article published on 18 January 2007

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

scientific article

A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis

scientific article published on 10 September 2011

A review of POEMS syndrome

scientific article

A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis

scientific article published on 23 July 2020

A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference

scientific article published on 11 June 2018

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

scientific article published on 26 May 2005

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

scientific article published on 14 April 2020

AL patients don't dare go without dara

scientific article published on 01 April 2020

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging

scientific article published on 29 August 2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization

scientific article published on 29 August 2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging

scientific article published on 01 December 2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

scientific article published on 29 August 2019

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

scientific article published on 17 November 2013

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

scientific article published on May 2015

Abnormal stress echocardiography findings in cardiac amyloidosis

scientific article

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 5 January 2006

Abstracts

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

scientific article

Achievability to Extract Specific Date Information for Cancer Research

scientific article published on 01 January 2019

Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

scientific article published on 9 March 2004

Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma.

scientific article

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

scientific article

Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis

scientific article published on 11 November 2011

Acute neuropathies after peripheral blood stem cell and bone marrow transplantation

scientific article published on 01 December 2003

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

scientific article published in January 2005

Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy

scientific article published on 18 January 2014

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

scientific article published on 01 June 2006

Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples

scientific article published on 01 September 2020

Amyloidosis

scientific article published on 01 January 2005

Amyloidosis and POEMS syndrome

scientific article

Amyloidosis.

scientific article

Amyloidosis: 2008 BMT Tandem Meetings (February 13-17, San Diego).

scientific article published on January 2008

Amyloidosis: diagnosis and management

scientific article

Amyloidosis: recognition, confirmation, prognosis, and therapy

scientific article published on 01 May 1999

An internationally recognized uniform cytogenetic classification system is needed for multiple myeloma

scientific article published on 01 January 2007

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma

scientific article published on 12 April 2018

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome

scientific article published on 31 October 2002

Aortic valve replacement in patients with amyloidosis

scientific article published on 19 December 2017

Apolipoprotein A-IV-Associated Cardiac Amyloidosis

scientific article published on 01 May 2017

Appraisal of immunoglobulin free light chain as a marker of response

scientific article

Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients

scientific article published on 06 July 2018

Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept

scientific article

Association between Choroidal Characteristics and Systemic Severity in Amyloidosis

scientific article published on 18 August 2020

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study

scientific article published on 01 May 2019

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

scientific article published on 20 July 2010

Attenuated oncolytic measles virus strains as cancer therapeutics

scientific article published in July 2012

Attitudes about when and how to treat patients with AL amyloidosis: an international survey.

scientific article published on 31 August 2017

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

scholarly article by M Hasib Sidiqi et al published March 2019 in Biology of Blood and Marrow Transplantation

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

scientific article published on 20 June 2018

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma

scientific article

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy

scientific article

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

scientific article published on 20 October 2010

Autologous stem cell transplant for multiple myeloma patients 70 years or older

scientific article published on 4 July 2016

Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

scientific article

Autologous stem cell transplantation and IgM amyloidosis

scientific article published on June 2006

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

scientific article published on 04 December 2020

Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency

scientific article published on 25 July 2015

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis

scientific article published in August 2008

Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function

scientific article published on 08 April 2019

Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab

scientific article published on 04 August 2020

Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes

scientific article published on 11 March 2020

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

scientific article published on 03 April 2018

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

scientific article published on 12 October 2016

Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

scientific article

Biology, treatment, and time

scientific article published on 01 October 2008

Blaming the Right Fluorescent in Situ Hybridization

scientific article published on 31 August 2015

Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.

scientific article published on 23 June 2017

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

scientific article published on 25 February 2020

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis

scientific article published on 01 July 2002

Bone marrow angiogenesis in multiple myeloma: effect of therapy

article

Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients

scientific article

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Bortezomib for myeloma -- much ado about something

scientific article published in June 2005

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

scientific article published on 22 December 2016

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal

CNV Radar: an improved method for somatic copy number alteration characterization in oncology

scientific article published on 06 March 2020

Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis.

scientific article published on 25 February 2017

Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week

scientific article published on 01 June 2020

Cardiac amyloidosis in aortic stenosis-icebergs and Archimedes' principle

scientific article published on 01 September 2018

Castleman Disease

scientific article published on 01 January 2008

Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis

scientific article published on 16 July 2016

Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics.

scientific article published on October 2009

Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy

scientific article published on 13 January 2012

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

scientific article published on 15 February 2011

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

scientific article published on 16 June 2017

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.

scientific article

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

scientific article published on 02 July 2020

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

scientific article published on 28 June 2019

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

scientific article published on 01 February 2003

Chronic myopathy due to immunoglobulin light chain amyloidosis

scientific article published on 4 February 2013

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

scientific article published on 05 September 2002

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

scientific article published on 16 June 2005

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

scientific article published on 07 January 2021

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry

scientific article published on 16 November 2016

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

scientific article

Classification of Plasma Cell Disorders by 21 Tesla Fourier Transform Ion Cyclotron Resonance Top-Down and Middle-Down MS/MS Analysis of Monoclonal Immunoglobulin Light Chains in Human Serum

scientific article published on 25 February 2019

Clinical Course and Prognosis of Non-Secretory Multiple Myeloma

scientific article

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

article

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies

scientific article published on 5 May 2016

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

scientific article published on 22 February 2017

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both

scientific article published on 12 May 2015

Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease

scientific article published on 11 September 2014

Clinical characteristics and outcomes in biclonal gammopathies

scientific article published on 3 February 2016

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

scientific article published on 01 August 2020

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

scientific article published on 11 April 2016

Clinical course and prognosis of non-secretory multiple myeloma

scientific article

Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study

scientific article

Clinical course of patients with relapsed multiple myeloma

scientific article published in July 2004

Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics

scientific article

Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres

scientific article published on 6 January 2014

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma ⬇️

scientific article

Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney

scientific article published on 07 November 2011

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

scientific article published on 05 March 2019

Clinical implication of centrosome amplification in plasma cell neoplasm

scientific article published on 22 December 2005

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

scientific article published on 23 June 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

scientific article published on 29 April 2009

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

scientific article published on 18 September 2017

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

scientific article published on 29 March 2017

Clinical reasoning: a 40-year-old man with CIDP-like illness resistant to treatment

scientific article published on September 2013

Clinical relevance of pulmonary amyloidosis: an analysis of 76 autopsy-derived cases

article

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma

scientific article published in November 1999

Clinical spectrum of Castleman disease-associated neuropathy

scientific article published on 2 November 2016

Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview

scientific article published on February 2009

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

scientific article published on 17 February 2017

Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies

scientific article published on 13 March 2012

Clonal competition with alternating dominance in multiple myeloma.

scientific article

Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration

scientific article published on October 2015

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

scientific article published on 21 October 2013

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

scientific article published on 23 August 2005

Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial

scientific article

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

scientific article published in November 2002

Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.

scientific article published on 16 August 2018

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

scientific article published on 10 November 2008

Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohor

scientific article published on 3 February 2012

Complex p.T88N/W130R mutation in the lysozyme gene leading to hereditary lysozyme amyloidosis with biopsy-proven cardiac involvement

scientific article published on 22 March 2017

Complications of myeloma therapy

scientific article published on December 2007

Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

scientific article

Comprehensive assessment of potential multiple myeloma immunoglobulin heavy chain V-D-J intraclonal variation using massively parallel pyrosequencing

scientific article

Computed tomography assessment of bone lesions in patients with POEMS syndrome

scientific article published on 25 September 2014

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

scientific article

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

scientific article published on 05 April 2012

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

scientific article published on 25 October 2013

Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

scientific article published on 13 October 2020

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

scientific article

Correction: Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients

scientific article published on 01 April 2019

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 29 July 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

scientific article published on 11 December 2020

Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases

scientific article published on 28 September 2015

Corrigendum to “Quantitative analysis of clonal bone marrow CD19+ B cells: Use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis” [Clin. Immunol. 120 (2006) 106–120]

scholarly article published in Clinical Immunology

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization

scientific article published on 23 August 2012

Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma

scientific article published on 18 August 2014

Current Therapies for Light-Chain Amyloidosis

Current status of stem cell transplantation for multiple myeloma

scientific article

Cutaneous manifestations in patients with POEMS syndrome

scientific article published on 04 April 2013

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma

scientific article published on 01 March 2006

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

scientific article published on 09 October 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

scientific article published on 11 August 2020

DIAGNOSIS AND TREATMENT OF POEMS SYNDROME

Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement

scientific article published on 11 March 2020

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

scientific article published on 28 September 2018

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression

article

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

scientific article published on 14 August 2017

Department of Error

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

scientific article published on 20 February 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

scientific article published on 18 November 2020

Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma

scientific article published on October 2006

Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement

scientific article published on 13 December 2019

Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography

scientific article published on 26 June 2007

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

scientific article published on 16 May 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

scientific article published on 08 August 2017

Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis

scientific article

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

scientific article

Diagnosis of monoclonal gammopathy of renal significance

scientific article

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

scientific article

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

scientific article published on 01 May 2020

Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry

article

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis

Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry

scientific article published on 06 June 2019

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

scientific article published on October 2010

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.

scientific article published on 6 July 2018

Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients

scientific article published on August 2009

DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.

scientific article published on 2 November 2017

Doppler Myocardial Imaging Compared to Standard Two-Dimensional and Doppler Echocardiography for Assessment of Diastolic Function in Patients With Systemic Amyloidosis

scientific article published on 01 January 2009

Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis

scientific article published on 01 June 2011

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis

scientific article published on 01 February 2005

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

scientific article published on 01 August 2001

Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.

scientific article

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

scientific article published on 16 November 2017

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

scientific article

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

scientific article published on 25 August 2011

Effect of Systemic Therapies on Outcomes following Vertebroplasty among Patients with Multiple Myeloma.

scientific article

Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

scientific article

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

scientific article published on 01 November 2000

Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response

scientific article published on 01 October 2007

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

scientific article

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

scientific article published in March 2004

Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice-certified tissue banking facility

scientific article

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

scientific article published on 01 January 2019

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

scientific article published on 25 October 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

scientific article published on 11 August 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

scientific article

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma

scientific article published on 05 April 2011

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation

scientific article published on 13 November 2017

Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis

scientific article

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

scientific article

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

scientific article published in July 2001

Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays

scientific article

Endocrinopathy in POEMS syndrome: the Mayo Clinic experience

scientific article published in July 2007

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

scientific article published on 08 January 2020

Erratum: Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT

scholarly article published in Bone Marrow Transplantation

Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis

scholarly article published in Leukemia

Evaluation and monitoring of response to therapy in multiple myeloma

scientific article published on 01 October 2005

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

scientific article published on 13 July 2012

Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie

scientific article

Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX

scientific article published on 13 May 2011

Evidence of Impaired Left Ventricular Systolic Function by Doppler Myocardial Imaging in Patients With Systemic Amyloidosis and No Evidence of Cardiac Involvement by Standard Two-Dimensional and Doppler Echocardiography

article

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study

scientific article published on 14 October 2009

Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

scientific article published on 13 October 2015

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

scientific article published on 29 July 2016

Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients

scientific article published on 21 July 2005

Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry

scientific article

FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia

scientific article published on 01 July 2004

Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma

scientific article published in May 2009

Feasibility study of cardiac magnetic resonance elastography in cardiac amyloidosis

scientific article published in March 2017

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

scientific article published on 11 July 2019

Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review

scientific article published on 12 April 2018

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

scientific article published on 17 November 2017

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis

scientific article published on 31 March 2016

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.

scientific article published on 17 February 2006

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

scientific article published on 8 December 2005

Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease

scientific article published on 29 November 2008

Free light-chains and renal disorders: when small is worse – Authors' reply

scientific article published in The Lancet

Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis

scientific article published on 07 October 2014

Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis

article

Future Perspectives

scientific article published on 01 December 2020

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

scientific article

Genetic aberrations and survival in plasma cell leukemia

scientific article published on 24 January 2008

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

scientific article published on July 2016

Genotype, echocardiography, and survival in familial transthyretin amyloidosis.

scientific article published on 16 October 2013

Glycosylation of Immunoglobulin Light Chains is Highly Prevalent in Cold Agglutinin Disease

scientific article published on 01 May 2020

HLA polymorphism and risk of multiple myeloma

scientific article published on 27 July 2016

Heavy Chain Fibrillary Glomerulonephritis: A Case Report

scientific article published on 05 April 2019

Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits

scientific article published on May 2015

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

scientific article published on 9 February 2017

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma

scientific article published on 14 December 2013

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

scientific article published on November 2011

Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma

scientific article published on 29 September 2011

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

scientific article published on 29 October 2019

Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro

scientific article published in December 2003

Hereditary ATTR amyloidosis: a single-institution experience with 266 patients

scientific article published on 27 May 2015

Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype

scientific article published on 3 January 2017

High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis

scientific article published in August 2001

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.

scientific article published on 20 August 2012

High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa

scientific article published on 14 June 2011

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

scientific article published on 08 January 2014

High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis

scientific article published on 15 September 2009

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

scientific article published on 01 January 2008

High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

scientific article

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

scientific article published on 6 December 2011

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

scientific article

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

scientific article

How I treat POEMS syndrome

scientific article

How I treat monoclonal gammopathy of renal significance (MGRS).

scientific article published on 09 October 2013

IAP antagonists induce anti-tumor immunity in multiple myeloma.

scientific article

IMWG consensus on risk stratification in multiple myeloma

scientific article published on 26 August 2013

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.

scientific article published on February 2006

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

scientific article

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

scientific article published on 28 November 2019

IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Waldenström's Macroglobulinemia (SWM)

scientific article published on 01 February 2011

IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia

scientific article published on March 2009

IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

scientific article published on November 2010

IgM myeloma: A multicenter retrospective study of 134 patients

scientific article published on 6 April 2017

Imaging evidence for renomegaly in patients with POEMS syndrome

scientific article published on 22 July 2011

Immunoglobulin D amyloidosis: a distinct entity

scientific article published on 07 November 2011

Immunoglobulin Light Chain Systemic Amyloidosis

scientific article

Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy

scientific article

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

scientific article

Immunoglobulin free light chains and solitary plasmacytoma of bone

scientific article

Immunoglobulin light chain amyloidosis and the kidney

scientific article

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias

scientific article published on 02 September 2014

Immunoglobulin light-chain amyloidosis: growing recognition, new approaches to therapy, active clinical trials

scientific article published on February 1, 2012

Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia

scientific article published on 13 March 2013

Immunoglobulins and Laboratory Recognition of Monoclonal Proteins

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

scientific article published on 23 May 2016

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

scientific article published on 16 June 2016

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics

scientific article published on 20 January 2017

Impact of acquired del(17p) in multiple myeloma

scientific article published on 01 July 2019

Impact of additional cytoreduction following autologous SCT in multiple myeloma.

scientific article published on 16 June 2008

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma

scientific article published on 19 March 2007

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

scientific article published on 21 October 2015

Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma

scientific article

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

scientific article published on 29 April 2018

Impact of early relapse after auto-SCT for multiple myeloma.

scientific article published on 30 June 2008

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

scientific article published on 27 September 2017

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

scientific article published on 21 June 2007

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

scientific article published on 03 February 2020

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

scientific article

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma

scientific article published on 7 July 2016

Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma

scientific article

Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.

scientific article published on 10 March 2008

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

scientific article published on 21 March 2013

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

scientific article published on 21 December 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

scientific article published on 26 March 2009

Implantable cardioverter defibrillators in patients with cardiac amyloidosis

scientific article published on 14 March 2013

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

scientific article published on 02 October 2020

Implications of continued response after autologous stem cell transplantation for multiple myeloma

scientific article published on 17 July 2013

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

scientific article published on 20 November 2020

Importance of FISH genetics in light chain amyloidosis

scientific article published on 19 September 2017

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

scientific article

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

scientific article

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

scientific article published on 26 January 2017

Improved survival in multiple myeloma and the impact of novel therapies

scientific article

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

scientific article

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

scientific article published on 2 April 2008

In Reply

In reply

In vivo and in silico studies on single versus multiple transplants for multiple myeloma

scientific article published on 14 March 2007

Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

scientific article published on 25 February 2011

Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition

scientific article published on 7 August 2012

Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation

scientific article published on 06 June 2013

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma

scientific article

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Increased Myocardial Stiffness Detected by Intrinsic Cardiac Elastography in Patients With Amyloidosis: Impact on Outcomes

scientific article published on 17 October 2018

Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation ⬇️

scientific article published on March 30, 2012

Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma

scientific article

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

scientific article published on 29 January 2009

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

scientific article published on 01 May 2018

Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study

scientific article

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

scientific article published on February 2009

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

scientific article published on 24 June 2016

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

scientific article published on 07 September 2020

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

scientific article

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

scientific article published on 04 June 2009

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

scientific article

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

scientific article published on 01 December 2020

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease

scientific article

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

scientific article published on 04 September 2018

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

scientific article

Is early, deep free light chain response really an adverse prognostic factor?

scientific article published on 01 February 2008

Is there a future for auto-allo HSCT in multiple myeloma?

scientific article

Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties

scientific article published on 01 January 2008

Ixazomib-induced thrombotic microangiopathy.

scientific article

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders

scientific article published on 30 May 2018

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

scientific article published on 16 January 2015

LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis

scientific article

Laboratory persistence and clinical progression of small monoclonal abnormalities

scientific article published on October 2012

Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques

scientific article published on 9 December 2004

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction

scientific article

Left ventricular device implantation for advanced cardiac amyloidosis

scientific article published on 6 March 2013

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

scientific article published on September 2014

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

scientific article

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

scientific article

Lenalidomide therapy in a patient with POEMS syndrome

scientific article published on 01 August 2007

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

scientific article published on 31 May 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

scientific article

Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

article

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

scientific article published on 01 April 2018

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

scientific article

Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement

scientific article published in July 2005

Localized AL amyloidosis of the colon: an unrecognized entity

scientific article published in March 2003

Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate

scientific article published on 9 October 2012

Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience

scientific article published on June 2016

Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

scientific article published in January 2018

Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience

scientific article published on 07 October 2020

Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies

scientific article published on 6 October 2011

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

scientific article published on 18 February 2014

Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation

scientific article

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years

scientific article

Long-term outcome of autologous stem cell transplantation in light chain deposition disease

scientific article published on 4 January 2008

Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits

scientific article published on 26 November 2008

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

scientific article published on 11 March 2016

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

scientific article published on 05 August 2013

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

scientific article published on 07 May 2013

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

scientific article

Long-term outcomes after autologous stem cell transplantation in patients with POEMS syndrome

scientific article published on 01 November 2012

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

scientific article published on 08 January 2020

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

scientific article published on 4 May 2011

Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.

scientific article

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

scientific article published in October 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

scientific article

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

scientific article published on 16 November 2020

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous

scientific article published on 11 May 2020

Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.

scientific article published on 20 June 2013

Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization

scientific article

MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms

scientific article published on 21 September 2018

MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis

scientific article published on 07 May 2018

MRI of pathology-proven peripheral nerve amyloidosis

scientific article published on 12 October 2016

MYC dysregulation in the progression of multiple myeloma

scientific article published on 22 August 2019

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

scientific article published on 28 October 2017

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis

scientific article published on 23 May 2019

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

scientific article published on 28 October 2011

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies

scientific article published on 28 August 2019

Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome

scientific article published on 20 February 2020

Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis

scientific article

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

scientific article published on August 2006

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

scientific article published on 14 January 2011

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

scientific article published on 01 May 2020

Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation

article

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies

scientific article published on 19 April 2013

Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays

scientific article published on 01 December 2014

Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC–MS/MS

scientific article published on 05 March 2014

Monitoring free light chains in serum using mass spectrometry

scientific article published on 01 June 2016

Monoclonal gammopathies

scientific article published in 2008

Monoclonal gammopathies of clinical significance

scientific article published on 01 December 2020

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications

scholarly article by Jean-Paul Fermand et al published 4 October 2018 in Blood

Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant

scientific article published on 09 October 2012

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

scientific article

Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment

scientific article

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

scientific article published on 27 February 2019

Monoclonal gammopathy-associated thrombotic microangiopathy

scientific article published on 17 July 2019

Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis

scientific article published on 24 August 2016

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Multiple myeloma after kidney transplantation

scientific article published on 7 December 2014

Multiple myeloma in the very old: an IASIA conference report

scientific article published on 3 April 2014

Multiple myeloma: clinical features and indications for therapy

scientific article

Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis

scientific article

Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement

scientific article

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report

scientific article

Myeloma in Elderly Patients: When Less Is More and More Is More

scientific article published in January 2017

Myeloma: management of the newly diagnosed high-risk patient.

scientific article

Myelomatous Involvement of the Central Nervous System

scientific article

Myocardial Stiffness by Intrinsic Cardiac Elastography in Patients with Amyloidosis: Comparison with Chamber Stiffness and Global Longitudinal Strain

scientific article published on 21 June 2019

N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression

scientific article published on 27 June 2020

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

scientific article published on 10 August 2016

Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

scientific article

Natural history and therapy of 66 patients with mixed cryoglobulinemia

scientific article published in July 2006

Natural history and therapy of AL cardiac amyloidosis

scientific article

Natural history of amyloidosis isolated to fat and bone marrow aspirate

scientific article published on 22 June 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Natural history of t(11;14) multiple myeloma

scientific article

Natural history of thromboembolism in AL amyloidosis

scientific article

Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation

scientific article published on 11 January 2007

Nerve pathologic features differentiate POEMS syndrome from CIDP.

scientific article published on 31 October 2016

Neurological aspects of multiple myeloma and related disorders

scientific article

New cancers after autotransplantations for multiple myeloma

scientific article

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

scientific article published on 22 October 2012

New developments in diagnosis, risk assessment and management in systemic amyloidosis

scientific article published on 02 November 2019

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab

scientific article published on 31 October 2020

Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis

scientific article published on 05 December 2020

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

scientific article published on 22 April 2016

Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

scientific article published on 13 June 2016

Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis

scientific article published on 28 December 2006

Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma

scientific article published in October 2007

OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.

scientific article published on 24 October 2017

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

scientific article

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

scientific article published on 11 March 2016

Ocular Manifestations of Familial Transthyretin Amyloidosis

scientific article published on 11 September 2017

Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome

scientific article

Older patients with myeloma derive similar benefit from autologous transplantation.

scientific article

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

scientific article published on 22 June 2019

Oncolytic measles virus targets high CD46 expression on multiple myeloma cells

scientific article published in June 2006

Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma

scientific article published on 23 April 2020

Opening a can of worms in AL progression

scientific article published in February 2018

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders

scientific article published on 3 March 2008

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p

scientific article published on 25 July 2018

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study

scientific article

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis

scientific article published on 01 November 2018

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant

scientific article published on 2 March 2014

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

scientific article published on 17 October 2020

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation

scientific article published on 4 July 2017

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

scientific article published on 02 May 2019

Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation

scientific article published on 14 August 2017

Outcomes of patients with POEMS syndrome treated initially with radiation

scientific article

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

scientific article published on 8 August 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

scientific article published on 27 July 2015

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

scientific article published on 12 March 2019

Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

scientific article published on 09 June 2020

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

scientific article published on 8 March 2017

Overview of Castleman Disease

scientific article published on 27 February 2020

POEMS Syndrome

scientific article

POEMS Syndrome and Castleman’s Disease

POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management

scientific article published on 23 May 2019

POEMS Syndrome: Diagnosis and Investigative Work-up

scientific article published in February 2018

POEMS syndrome

scientific article

POEMS syndrome and paraproteinemic syndromes: management and follow-up

POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management

scientific article published on July 2011

POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management

scientific article

POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management

scientific article

POEMS syndrome: Update on diagnosis, risk‐stratification, and management ⬇️

scientific article published on 01 August 2012

POEMS syndrome: definitions and long-term outcome

scientific article

POEMS syndrome: update on diagnosis, risk-stratification, and management

scientific article

PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis

scientific article published on July 2005

Pathophysiology and treatment of cardiac amyloidosis

scientific article

Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab

scientific article

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center

scientific article published on 22 April 2013

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

scientific article published on 23 January 2008

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

scientific article published on 27 July 2004

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

scientific article

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

scientific article

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

scientific article

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

scientific article

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

scientific article published on 20 March 2015

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia

scientific article

Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry

scientific article published on 26 August 2014

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

scientific article published on 07 August 2018

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation

scientific article published on 19 April 2018

Ploidy status rarely changes in myeloma patients at disease progression.

scientific article

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

scholarly article by Shaji Kumar et al published 17 May 2019 in Blood Cancer Journal

Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus

scientific article published on 25 November 2011

Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.

scientific article published on 15 April 2015

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

scientific article

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

scientific article

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

scientific article published on 20 June 2011

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

scientific article

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

scientific article published on September 2017

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma.

scientific article published on 06 September 2013

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

scientific article published in December 2003

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

scientific article

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

scientific article

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

scientific article

Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.

scientific article

Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification

scientific article published on 6 November 2013

Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study

scientific article published on 10 April 2008

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

scientific article published on 6 July 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

scientific article

Predictors of short-term survival in Waldenström Macroglobulinemia

scientific article published on 14 July 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

scientific article published on 5 May 2017

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

scientific article published on 24 April 2017

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

scientific article

Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana

Prevalence of monoclonal gammopathy of undetermined significance

scientific article

Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana

scientific article

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.

scientific article published on 20 October 2017

Prevalence, incidence and survival of smoldering multiple myeloma in the United States

scientific article published on 21 October 2016

Primary cardiac amyloidosis with 20-year survival

article

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

scientific article published on 12 October 2018

Primary systemic amyloidosis with ischemic stroke as a presenting complication

scientific article published on September 2007

Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial.

scientific article

Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System

scientific article published on 8 September 2016

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

scientific article published on 15 May 2020

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

scientific article published on 02 February 2019

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

scientific article published on 30 June 2018

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

article

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations

scientific article

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

scientific article published in September 2017

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

scientific article

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

scientific article published on 08 February 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

scientific article published on 21 February 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

scientific article published on 04 July 2020

Prognostic value of angiogenesis in solitary bone plasmacytoma

scientific article published on 17 October 2002

Prognostic value of bone marrow angiogenesis in multiple myeloma

scientific article published on 01 August 2000

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

scientific article published in August 2004

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

scientific article published on 05 October 2006

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

scientific article published on 30 April 2019

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

scientific article

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 25 March 2004

Progression in smoldering Waldenstrom macroglobulinemia: long-term results

scientific article

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

scientific article

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

scientific article published on 01 February 2019

Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients

scientific article published on 15 January 2008

Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome

scientific article published on 14 November 2014

Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

scientific article published on 26 July 2016

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

scientific article

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

scientific article

Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis

scientific article published on 3 March 2006

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey

scientific article

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

scientific article published on 4 October 2016

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

scientific article published on 08 January 2019

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis

scientific article

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

scientific article

Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016.

scientific article published in March 2017

Recurrent membranoproliferative glomerulonephritis after kidney transplantation

scientific article

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

scientific article published on 10 September 2012

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

scientific article published on 18 July 2020

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

scientific article published on 15 October 2018

Relationship Between Depth of Response and Outcome in Multiple Myeloma

scientific article published on 01 November 2007

Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

scientific article published on 3 June 2010

Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.

scientific article published on 05 September 2013

Relationship between monoclonal gammopathy and cardiac amyloid type.

scientific article

Remission of disseminated cancer after systemic oncolytic virotherapy

scientific article

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis

scientific article

Renal risk and response in amyloidosis

scientific article published on 01 October 2014

Reply

scientific article published on 13 December 2017

Reply to S. Girnius et al.

scientific article published in July 2013

Reply: Cardiac Amyloidosis, Atrial Arrhythmias, Thrombus, and Stroke: A Vexing Problem

scientific article published on 01 June 2019

Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myeloma

scientific article

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

scientific article published in January 2003

Response to rituximab in patients with type II cryoglobulinemia

scientific article published on 01 September 2006

Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy

scientific article published on 11 October 2011

Retroperitoneal involvement with light chain amyloidosis- case series and literature review

scientific article published on 29 October 2020

Retrospective cohort study of 148 patients with polyclonal gammopathy

scientific article

Review of 1027 patients with newly diagnosed multiple myeloma

scientific article

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

scientific article published on 13 February 2012

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival

scientific article published on 10 April 2017

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

scientific article published on 16 December 2015

Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients

scientific article published on 5 February 2013

Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.

scientific article published on 16 December 2016

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

scientific article

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

scientific article published on 01 December 2004

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

scientific article published in February 2010

S0120 G.E.M.S.: genomics encounters MGUS and SMM

scientific article published on 01 January 2014

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

scientific article published on 25 October 2010

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

scientific article published in January 2018

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

scientific article published on 02 November 2018

Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects

scientific article published on 27 October 2017

Salvage second hematopoietic cell transplantation in myeloma

scientific article

Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

scientific article published on 11 August 2016

Screening algorithms for monoclonal gammopathies

scientific article published in November 2008

Screening panels for detection of monoclonal gammopathies

scientific article published on 11 June 2009

Second auto-SCT for treatment of relapsed multiple myeloma

scientific article published on 24 September 2012

Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation

scientific article

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

scientific article

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation

scientific article published on 4 May 2017

Serum M-spike and transplant outcome in patients with multiple myeloma

scientific article

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

scientific article published in September 2004

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias

scientific article published on January 2011

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

scientific article published on 16 October 2012

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

scientific article

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

scientific article

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

scientific article

Serum uric acid: novel prognostic factor in primary systemic amyloidosis

scientific article

Severity of Baseline Proteinuria Predicts Renal Response in Immunoglobulin Light Chain-Associated Amyloidosis after Autologous Stem Cell Transplantation

scientific article published on 04 April 2007

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

scientific article published on 01 September 2004

Skull base plasmacytoma: A unique case of POEMS syndrome with a plasmacytoma causing craniocervical instability

scientific article published on 31 October 2017

Smoldering multiple myeloma requiring treatment: time for a new definition?

scientific article

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

scientific article

Specificity of Serum and Urine Protein Electrophoresis for the Diagnosis of Monoclonal Gammopathies

scientific article published on 15 September 2010

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

scientific article published on 13 December 2018

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time

scientific article published on 20 March 2018

Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis

scientific article published on 03 May 2016

Stem cell transplantation for the management of primary systemic amyloidosis

scientific article

Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction

scientific article published on 20 January 2010

Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis

scientific article published on 01 March 2010

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

scientific article published on 01 December 2014

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death

scientific article published on 08 January 2010

Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation

scientific article

Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation

scientific article published in October 2005

Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS

scientific article published on 11 April 2012

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

scientific article published on 22 January 2004

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.

scientific article published on 11 July 2012

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

scientific article

Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma

scientific article published on 19 January 2006

Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review

scientific article published on 01 July 2020

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

scientific article published on October 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 19 March 2013

Systemic amyloidosis from A (AA) to T (ATTR): a review

scientific article published on 14 September 2020

Systemic immunoglobulin light chain amyloidosis

Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis

scientific article

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

scientific article published on 06 February 2019

Thalidomide as initial therapy for early-stage myeloma

scientific article published in April 2003

Thalidomide for previously untreated indolent or smoldering multiple myeloma

scientific article published in August 2001

Thalidomide in the treatment of relapsed multiple myeloma

scientific article published on 01 September 2000

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias

scientific article published on 16 March 2020

The Novel Form of Amyloidosis Derived From EGF-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Preferentially Affects the Lower Gastrointestinal Tract of Elderly Females

scientific article published on 05 October 2020

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

scientific article

The clinical spectrum of Castleman's disease

scientific article published on 13 July 2012

The definition of IgM multiple myeloma

scholarly article by Steven R. Schuster et al published 14 July 2011 in American Journal of Hematology

The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis

scientific article

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

scientific article published on June 2004

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma

scientific article published on September 2005

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

scientific article published on 01 January 2019

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

scientific article published on 30 November 2015

The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents.

scientific article

The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

scientific article published on 12 June 2019

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma

scientific article published on 29 July 2009

The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response

scientific article published on 30 January 2018

The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.

scientific article published on March 2011

The pathogenesis and diagnosis of acute kidney injury in multiple myeloma

scientific article

The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma

scientific article published on 10 March 2016

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

scientific article published on 31 May 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

scientific article

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry

scientific article published on 25 June 2019

The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis

scientific article published on 23 January 2020

The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic

scientific article

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

The yin and yang of autophagy in AL amyloidosis

scientific article published in April 2017

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

scientific article published on 10 March 2017

Therapy for immunoglobulin light chain amyloidosis: the new and the old.

scientific article published on March 2004

Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents

article

Thermal stability threshold for amyloid formation in light chain amyloidosis

scientific article

Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.

scientific article published on 14 July 2015

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

scientific article published on 16 April 2018

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

scientific article published on 11 February 2009

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis

scientific article published on 01 October 2001

Transplantation for amyloidosis

scientific article published on March 2007

Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).

scientific article published on 10 September 2007

Transthyretin amyloidosis in patients with undifferentiated heart failure

scientific article published on 01 January 2019

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome

scientific article (published 2012-06-13)

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome

scientific article

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome

scientific article (published 2007-10-17)

Treatment for high-risk smoldering myeloma

scientific article published in October 2013

Treatment of Castleman's disease

scientific article

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Treatment of POEMS syndrome

scientific article published on June 2004

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

scientific article published on March 2007

Treatment options for POEMS syndrome

scientific article

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

article

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

scientific article published on 17 March 2017

Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies

scientific article published on 19 September 2013

Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006 ⬇️

scientific article published on June 1, 2011

Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic

scientific article published on 02 April 2015

Trends and outcomes of modern staging of solitary plasmacytoma of bone

scientific article published on 2 May 2012

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

scientific article

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.

scientific article

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

scientific article

Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma

scientific article

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

scientific article published on 10 January 2012

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis

scientific article

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

scientific article published on 13 July 2006

Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma

scientific article

Two types of amyloidosis presenting in a single patient: a case series

scientific article published on 05 March 2019

Two-dimensional acoustic pattern derived strain parameters closely correlate with one-dimensional tissue Doppler derived strain measurements

scientific article published on 9 September 2005

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

scientific article published on 19 February 2013

Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.

scientific article published on 06 March 2012

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

scientific article

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

scientific article published on 01 December 2020

Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population

scientific article published on June 2012

Ushering in a new era for POEMS ⬇️

scientific article published on June 16, 2011

Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal Gammopathy

scientific article published on 11 February 2014

Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses

scientific article published on 5 April 2012

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

scientific article published on 02 October 2018

Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosi

scientific article

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

scientific article published on 02 October 2020

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

scientific article

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

scientific article published on 01 January 2020

Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure

scientific article published on 02 February 2019

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

scientific article

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

scientific article published on 04 March 2020

Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin

scientific article published on 15 November 2018

Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort.

scientific article

Vascular abnormalities in primary amyloidosis

scientific article published on 12 April 2007

Vascular endothelial growth factor and POEMS

scientific article published on 01 January 2006

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone

scientific article published on 19 January 2018

What do I need to know about immunoglobulin light chain (AL) amyloidosis?

scientific article published on 25 April 2012

Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis

scientific article published on 02 March 2014

Paulina is supported by:

About Paulina

Help